Bivision Pharmaceutical Inc., a clinical stage biopharmaceutical company, is engaged in the discovery, development and commercialization of targeted radionuclide therapy to address the significant unmet medical needs. We have extensive experience and expertise in the field of radiopharmaceuticals with following highlights:
